Avalo Therapeutics (AVTX)

Avalo Therapeutics (AVTX) stock research: performance, analysts' price targets, earnings, revenue and margins, technicals and insider trades.

• AVTX last traded at $7.32, 2.02% on the day.
• Avalo Therapeutics: P/E -1.5, revenue $1.07M over the last four quarters.
• Over the past year AVTX returned -59.44%; year to date -59.72%.

Updated 2026-11-03 02:46 UTC